SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PROTEOMICS

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mopgcw who wrote (391)1/30/2002 1:24:36 PM
From: tuck   of 539
 
>>Published online before print January 29, 2002
Proc. Natl. Acad. Sci. USA, 10.1073/pnas.032665299

Biochemistry

Probing protein conformational changes in living cells by using designer binding proteins: Application to the estrogen receptor

Akiko Koide, Stacy Abbatiello, Lisa Rothgery, and Shohei Koide*
Department of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642

Communicated by Fred Sherman, University of Rochester School of Medicine and Dentistry, Rochester, NY, December 12, 2001 (received for review September 20, 2001)

A challenge in understanding the mechanism of protein function in biology is to establish the correlation between functional form in the intracellular environment and high-resolution structures obtained with in vitro techniques. Here we present a strategy to probe conformational changes of proteins inside cells. Our method involves: (i) engineering binding proteins to different conformations of a target protein, and (ii) using them to sense changes in the surface property of the target in cells. We probed ligand-induced conformational changes of the estrogen receptor (ER) ligand-binding domain (LBD). By using yeast two-hybrid techniques, we first performed combinatorial library screening of "monobodies" (small antibody mimics using the scaffold of a fibronectin type III domain) for clones that bind to ER and then characterized their interactions with ER in the nucleus, the native environment of ER, in the presence of various ligands. A library using a highly flexible loop yielded monobodies that specifically recognize a particular ligand complex of ER, and the pattern of monobody specificity was consistent with the structural differences found in known crystal structures of ER-LBD. A more restrained loop library yielded clones that bind both agonist- and antagonist-bound ER. Furthermore, we found that a deletion of the ER F domain that is C-terminally adjacent to the LBD increased the crossreactivity of monobodies to the apo-ER-LBD, suggesting a dynamic nature of the ER-LBD conformation and a role of the F domain in restraining the LBD in an inactive conformation.

--------------------------------------------------------------------------------
* To whom reprint requests should be addressed. E-mail: shohei_koide@urmc.rochester.edu.

www.pnas.org/cgi/doi/10.1073/pnas.032665299<<

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext